|Day Low/High||3.45 / 3.58|
|52 Wk Low/High||3.33 / 6.96|
Barington Capital and partner NuOrion Partners own 3% of Avon's shares.
Jim Mitarotonda urged the beauty products company to start a search for replace its CEO, Sheri McCoy, after a poor quarter.
The Fed's intent is still as plain to see as it was late last year. This committee remains on mission.
'Sarge' Guilfoyle says that if it's possible to sniff out when a beaten-down stock can make a positive change, Avon could be it.
Investors in Avon Products, Inc. saw new options become available today, for the May 19th expiration.
Nu Skin's beauty secret makes it an attractive income opportunity.
- Avon proudly supports International Women's Day and its campaign for #BeBoldForChange by taking bold action against domestic violence
Insiders at GNC Holdings, American Express and three other companies have been scooping up shares of their own stock lately.
Investors overwhelmingly reject a shareholder proposal to increase diversity among senior management and directors.
Demand slumped across almost all of the company's markets.
The consumer finally has some fun money to spare. That is the good news.
U.S. stock futures pull back Thursday after Wall Street closes at records again on Wednesday, scoring the longest record-making streak since George H. W. Bush was in the White House.
Avon has the world's largest direct-selling workforce.
The makeup company's fourth-quarter results will be impacted by a strong dollar, analysts say.
Fed Chair Janet Yellen will give her two-day semiannual monetary policy testimony, while major economic data will drive markets.
Avon, Revlon, Iconix and Coca-Cola European Partners were the top players in January.
The most recent short interest data was recently released for the 01/13/2017 settlement date, and Avon Products, Inc. is one of the most shorted stocks of the Russell 3000, based on 5.66 "days to cover" versus the median component at 5.04.
Investors in Avon Products, Inc. saw new options begin trading today, for the March 17th expiration.
The firm does not see near-term catalysts for P&G over the next few quarters, but is positive in the medium to long term.